Formulation Issues around Lipid-Based Oral and Parenteral Delivery Systems

Role of Lipid Excipients in Modifying Oral and Parenteral Drug Delivery: Basic Principles and Biological Examples

Volumn , Issue , 2006, Pages 32-47

  Jeong, Seong Hoon ^a   Park, Jae Hyung ^a   Park, Kinam ^b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Drug delivery application lipid; Lipid based drug delivery formulations; Surface modification of liposome with polyethyleneglycol (PEG)

Indexed keywords

EID: 84889796768     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470097984.ch2     Document Type: Chapter

References (90)

1. Charman, W.N., Porter, C.J.H., Mithani, S., Dressman, J.B. Physicochemical and Physiological Mechanisms for the Effects of Food on Drug Absorption: The Role of Lipids and pH. J Pharm Sci 1997;86:269-282.
2. Humberstone, A.J., Charman, W.N. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev 1997;25:103-128.
3. Lukyanov, A.N., Torchilin, V.P. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv Drug Deliv Rev 2004;56:1273-1289.
4. Liao, T.H., Hamosh, P., Hamosh, M. Fat digestion by lingual lipase: mechanism of lipolysis in the stomach and upper small intestine. Pediatr Res 1984;18:402-409.
5. Hamosh, M., Scanlon, J.W., Ganot, D., Likel, M., Scanlon, K.B., Hamosh, P. Fat digestion in the newborn. Characterization of lipase in gastric aspirates of premature and term infants. J Clin Invest 1981;67:838-846.
6. Volpenhein, R.A., Webb, D.R., Jandacek, R.J. Effect of a nonabsorbable lipid, sucrose polyester, on the absorption of DDT by the rat. J Toxicol Env Health 1980;6:679-683.
7. Rozman, K., Ballhorn, L., Rozman, T. Mineral oil in the diet enhances fecal excretion of DDT in the rhesus monkey. Drug Chem Toxicol 1983;6:311-316.
8. Bloedow, D.C., Hayton, W.L. Effects of lipids on bioavailability of sulfisoxazole acetyl, dicumarol, and griseofulvin in rats. J Pharm Sci 1976;65:328-334.
9. Myers, R.A., Stella, V.J. Systemic bioavailability of penclomedine (NSC-338720) from oil-in-water emulsions administered intraduodenally to rats. Int J Pharm 1992;78:217-226.
10. Yamahira, Y., Noguchi, T., Takenaka, H., Maeda, T. Biopharmaceutical studies of lipid-containing oral dosage forms: relationship between drug absorption rate and digestibility of vehicles. Int J Pharm 1979;3:23-31.
11. Porter, C.J.H., Charman, W.N. In vitro assessment of oral lipid based formulations. Adv Drug Deliv Rev 2001;50:S127-S147.
12. Hunt, J.N., Knox, M.T. Relation between the chain length of fatty acids and the slowing of gastric emptying. J Physiol 1968;194:327-336.
13. Aungst, B.J. Intestinal permeation enhancers. J Pharm Sci 2000;89:429-442.
14. Dintaman, J.M., Silverman, J.A. Inhibition of P-glycoprotein by D-a-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res 1999;16:1550-1556.
15. Nerurkar, M.M., Burton, P.S., Borchardt, R.T. The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system. Pharm Res 1996;13:528-534.
16. Porter, C.J.H., Charman, W.N. Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev 2001;50:61-80.
17. Lipinski, C.A. Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 2000;44:235-249.
18. Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3-26.
19. Alkan-Onyuksel, H., Ramakrishnan, S., Chai, H.B., Pezzuto, J.M. Amixed micellar formulation suitable for the parenteral administration of taxol. Pharm Res 1994;11:206-212.
20. Kawakami, K., Miyoshi, K., Ida, Y. Solubilization behavior of poorly soluble drugs with combined use of Gelucire 44/14 and cosolvent. J Pharm Sci 2004;93:1471-1479.
21. Chambin, O., Jannin, V. Interest of multifunctional lipid excipients: case of Gelucire 44/14. Drug Dev Ind Pharm 2005;31:527-534.
22. Dye, D., Watkins, J. Suspected anaphylactic reaction to Cremophor EL. BMJ 1980;280:1353.
23. Hassan, S., Dhar, S., Sandstrom, M., Arsenau, D., Budnikova, M., Lokot, I., et al. Cytotoxic activity of a new paclitaxel formulation, Pacliex, in vitro and in vivo. Cancer Chemother Pharmacol 2005;55:47-54.
24. Constantinides, P.P., Tustian, A., Kessler, D.R. Tocol emulsions for drug solubilization and parenteral delivery. Adv Drug Deliv Rev 2004;56:1243-1255.
25. Park, K.M., Lee, M.K., Hwang, K.J., Kim, C.K. Phospholipid-based microemulsions of flurbiprofen by the spontaneous emulsification process. Int J Pharm 1999;183:145-154.
26. Constantinides, P.P., Lambert, K.J., Tustian, A.K., Schneider, B., Lalji, S., Ma, W., et al. Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel. Pharm Res 2000;17:175-182.
27. Straubinger, R.M., Arnold, R.D., Zhou, R., Mazurchuk, R., Slack, J.E. Antivascular and antitumor activities of liposome-associated drugs. Anticancer Res 2004;24:397-404.
28. Straubinger, R.M., Balasubramanian, S.V. Preparation and characterization of taxane-containing liposomes. Methods Enzymol 2005;391:97-117.
29. Pouton, C.W. Formulation of self-emulsifying drug delivery systems. Adv Drug Deliv Rev 1997;25:47-58.
30. Neslihan Gursoy, R., Benita, S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 2004;58:173-182.
31. Breitenbach, J. Melt extrusion: from process to drug delivery technology. Eur J Pharm Biopharm 2002;54:107-117.
32. Davis, S.S. Coming of age of lipid-based drug delivery systems. Adv Drug Deliv Rev 2004;56:1241-1242.
33. Mehnert, W., Mader, K. Solid lipid nanoparticles. Production, characterization and applications. Adv Drug Deliv Rev 2001;47:165-196.
34. Bangham, A.D., Horne, R.W. Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J Mol Biol 1964;12:660-668.
35. Wissing, S.A., Kayser, O., Muller, R.H. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 2004;56:1257-1272.
36. Feng, S.-S., Chien, S. Chemotherapeutic engineering: application and further development of chemical engineering principles for chemotherapy of cancer and other diseases. Chem Eng Sci 2003; 58:4087-4114.
37. Helfrich, W. Size of bilayer vesicles generated by sonication. Phys Lett A 1974;50A:115-116.
38. Mayer, L.D., Krishna, R., Bally, M.B. Liposomes for cancer therapy applications. In: Polymeric Biomaterials, 2nd edn. 2002, pp. 823-841.
39. Fielding, R.M., Abra, R.M. Factors affecting the release rate of terbutaline from liposome formulations after intratracheal instillation in the guinea pig. Pharm Res 1992;9:220-223.
40. Harashima, H., Kiwada, H. Liposomal targeting and drug delivery: kinetic consideration. Adv Drug Deliv Rev 1996;19:424-444.
41. Abra, R.M., Hunt, C.A. Liposome disposition in vivo. III. Dose and vesicle-size effects. BBA-Lipid Lipid Met 1981;666:493-503.
42. Senior, J., Gregoriadis, G. Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components. Life Sci 1982;30:2123-2136.
43. Klibanov, A.L., Maruyama, K., Torchilin, V.P., Huang, L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 1990;268:235-237.
44. Papahadjopoulos, D., Allen, T.M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S.K., et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA 1991;88:11460-11464.
45. Simoes, S., Moreira, J.N., Fonseca, C., Duzgunes, N., de Lima, M.C. On the formulation of pHsensitive liposomes with long circulation times. Adv Drug Deliv Rev 2004;56:947-965.
46. Guo, X., Szoka, F.C., Jr. Steric stabilization of fusogenic liposomes by a low-pH sensitive PEGdiortho ester-lipid conjugate. Bioconjug Chem 2001;12:291-300.
47. MacKay, J.A., Deen, D.F., Szoka, F.C. Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating. Brain Res 2005;1035:139-153.
48. Ishida, T., Harada, M., Wang, X.Y., Ichihara, M., Irimura, K., Kiwada, H. Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes. J Control Release 2005;105:305-317.
49. Judge, A., McClintock, K., Phelps, J.R., Maclachlan, I. Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes. Mol Ther 2006;13:328-337.
50. Sarbolouki, M.N., Toliat, T. Storage stability of stabilized MLV and REV liposomes containing sodium methotrexate (aqueous and lyophilized). PDA J Pharm Sci Technol 1998;52:23-27.
51. Brandl, M. Liposomes as drug carriers: a technological approach. Biotechnol Annu Rev 2001;7:59-85.
52. Glavas-Dodov, M., Fredro-Kumbaradzi, E., Goracinova, K., Simonoska, M., Calis, S., Trajkovic-Jolevska, S., Hincal, A.A. The effects of lyophilization on the stability of liposomes containing 5-FU. Int J Pharm 2005;291:79-86.
53. Yamada, Y., Shinohara, Y., Kakudo, T., Chaki, S., Futaki, S., Kamiya, H., Harashima, H. Mitochondrial delivery of mastoparan with transferrin liposomes equipped with a pH-sensitive fusogenic peptide for selective cancer therapy. Int J Pharm 2005;303:1-7.
54. Mizoue, T., Horibe, T., Maruyama, K., Takizawa, T., Iwatsuru, M., Kono, K., et al. Targetability and intracellular delivery of anti-BCG antibody-modified, pH-sensitive fusogenic immunoliposomes to tumor cells. Int J Pharm 2002;237:129-137.
55. Gaver, M.H., Wu, N.Z., Hong, K., Huang, S.K., Dewhirst, M.W., Papahadjopoulos, D. Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. Int J Radiat Oncol 1996;36:1177-1187.
56. Namiki, Y., Namiki, T., Date, M., Yanagihara, K., Yashiro, M., Takahashi, H. Enhanced photodynamic antitumor effect on gastric cancer by a novel photosensitive stealth liposome. Pharmacol Res 2004;50:65-76.
57. Gref, R., Minamitake, Y., Peracchia, M.T., Trubetskoy, V., Torchilin, V., Langer, R. Biodegradable long-circulating polymeric nanospheres. Science 1994;263:1600-1603.
58. Tobio, M., Gref, R., Sanchez, A., Langer, R., Alonso, M.J. Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm Res 1998;15:270-275.
59. Kataoka, K., Harada, A., Nagasaki, Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 2001;47:113-131.
60. Cudd, A., Bhogal, M., O'Mullane, J., Goddard, P. Formation of cage-like particles by poly(amino acid)-based block copolymers in aqueous solution. Proc Natl Acad Sci USA 1991;88:10855-10859.
61. Nakanishi, T., Fukushima, S., Okamoto, K., Suzuki, M., Matsumura, Y., Yokoyama, M., et al. Development of the polymer micelle carrier system for doxorubicin. J Control Release 2001;74:295-302.
62. La, S.B., Okano, T., Kataoka, K. Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl L-aspartate) block copolymer micelles. J Pharm Sci 1996;85:85-90.
63. Kabanov, A.V., Batrakova, E.V., Alakhov, V.Y. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release 2002;82:189-212.
64. Yokoyama, M., Sugiyama, T., Okano, T., Sakurai, Y., Naito, M., Kataoka, K. Analysis of micelle formation of an Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer by gel permeation chromatography. Pharm Res 1993;10:895-899.
65. Park, J.H., Kwon, S., Nam, J.O., Park, R.W., Chung, H., Seo, S.B., et al. Self-assembled nanoparticles based on glycol chitosan bearing 5beta-cholanic acid for RGD peptide delivery. J Control Release 2004;95:579-588.
66. Kim, K., Kwon, S., Park, J.H., Chung, H., Jeong, S.Y., Kwon, I.C., Kim, I.S. Physicochemical characterizations of self-assembled nanoparticles of glycol chitosan-deoxycholic acid conjugates. Biomacromolecules 2005;6:1154-1158.
67. Lee, S.C., Kim, C., Kwon, I.C., Chung, H., Jeong, S.Y. Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(epsilon-caprolactone) copolymer as a carrier for paclitaxel. J Control Release 2003;89:437-446.
68. Benahmed, A., Ranger, M., Leroux, J.C. Novel polymeric micelles based on the amphiphilic diblock copolymer poly(N-vinyl-2-pyrrolidone)-block-poly(D,L-lactide). Pharm Res 2001;18:323-328.
69. Son, Y.J., Jang, J.S., Cho, Y.W., Chung, H., Park, R.W., Kwon, I.C., et al. Biodistribution and antitumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. J Control Release 2003;91:135-145.
70. Na, K., Lee, K.H., Bae, Y.H. pH-sensitivity and pH-dependent interior structural change of selfassembled hydrogel nanoparticles of pullulan acetate/oligo-sulfonamide conjugate. J Control Release 2004;97:513-525.
71. Lukyanov, A.N., Gao, Z., Mazzola, L., Torchilin, V.P. Polyethylene glycol-diacyllipid micelles demonstrate increased accumulation in subcutaneous tumors in mice. Pharm Res 2002;19:1424-1429.
72. Torchilin, V.P., Lukyanov, A.N., Gao, Z., Papahadjopoulos-Sternberg, B. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc Natl Acad Sci USA 2003;100:6039-6044.
73. Vakil, R., Kwon, G.S. PEG-phospholipid micelles for the delivery of amphotericin B. J Control Release 2005;101:386-389.
74. Senior, J., Delgado, C., Fisher, D., Tilcock, C., Gregoriadis, G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: stud
75. Blume, G., Cevc, G. Molecular mechanism of the lipid vesicle longevity in vivo. Biochim Biophys Acta 1993;1146:157-168.
76. Bedu-Addo, F.K., Tang, P., Xu, Y., Huang, L. Interaction of polyethyleneglycol-phospholipid conjugates with cholesterol-phosphatidylcholine mixtures: sterically stabilized liposome formulations. Pharm Res 1996;13:718-724.
77. Edwards, K., Johnsson, M., Karlsson, G., Silvander, M. Effect of polyethyleneglycol-phospholipids on aggregate structure in preparations of small unilamellar liposomes. Biophys J 1997;73:258-266.
78. Torchilin, V.P., Omelyanenko, V.G., Papisov, M.I., Bogdanov, A.A., Jr, Trubetskoy, V.S., Herron, J.N., Gentry, C.A. Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochim Biophys Acta 1994;1195:11-20.
79. Gabizon, A.A. Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy. Cancer Invest 2001;19:424-436.
80. Gao, Z., Lukyanov, A.N., Singhal, A., Torchilin, V. Diacyllipid-polymer micelles as nanocarriers for poorly soluble anticancer drugs. Nano Lett 2002;2:979-982.
81. Gao, Z., Lukyanov, A.N., Chakilam, A.R., Torchilin, V.P. PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing. J Drug Target 2003;11:87-92.
82. Lizano, C., Weissig, V., Torchilin, V.P., Sancho, P., Garcia-Perez, A.I., Pinilla, M. In vivo biodistribution of erythrocytes and polyethyleneglycol-phosphatidylethanolamine micelles carrying the antitumour agent dequalinium. Eur J Pharm Biopharm 2003;56:153-157.
83. Kwon, S., Park, J.H., Chung, H., Kwon, I.C., Jeong, S.Y. Physicochemical characteristics of selfassembled nanoparticles based on glycol chitosan bearing 5beta-cholanic acid. Langmuir 2003;19:10188-10193.
84. Krishnadas, A., Rubinstein, I., Onyuksel, H. Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs. Pharm Res 2003;20:297-302.
85. Kataoka, K., Matsumoto, T., Yokoyama, M., Okano, T., Sakurai, Y., Fukushima, S., et al. Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J Control Release 2000;64:143-153.
86. Lavasanifar, A., Samuel, J., Kwon, G.S. Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. Adv Drug Deliv Rev 2002;54:169-190.
87. Hubbell, J.A. Materials science. Enhancing drug function. Science 2003;300:595-596.
88. Matsumura, Y., Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy:mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986;46:6387-6392.
89. Duncan, R. Polymer conjugates for tumour targeting and intracytoplasmic delivery. The EPR effect as a common gateway? Pharm Sci Technol Today 1999;2:441-449.
90. Lukyanov, A.N., Gao, Z., Torchilin, V.P. Micelles from polyethylene glycol/phosphatidylethanolamine conjugates for tumor drug delivery. J Control Release 2003;91:97-102.